4
Changes in Ownership
Starling Oncology, Inc. Filed Acc 0001628280-23-008832
Chief Operating Officer acquired 67,667 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Miller Matthew P Chief Operating Officer | 2023-03-17 | Grant or award | +67,667 | 242,992 | D | ||
| Derivatives | |||||||
| Miller Matthew P Chief Operating Officer | 2023-03-17 | Grant or award · Non-Qualified Stock Option (right to buy) | +169,169 | 169,169 | D | ||
Loading xslF345X04/wf-form4_167944655124135.xml…